Comparison of Single Versus Multicenter Outcomes for Pelvic Organ Prolapse Repair Using a Mesh-capturing Device
KIDS
1 other identifier
observational
319
0 countries
N/A
Brief Summary
Comparison of single versus multicenter outcomes for pelvic organ prolapse repair using a mesh-capturing device (The Uphold™ Vaginal Support System for apical and vaginal wall prolapse - Boston Scientific). 1-2 years follow up study comprison of 112 vs 207 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2016
CompletedFirst Submitted
Initial submission to the registry
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 13, 2017
CompletedOctober 23, 2019
October 1, 2019
1.1 years
February 1, 2017
October 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The rate of immediate complications
Serious surgical complications are categorized as any surgical event which is potentially life-threatening related to the surgical procedure including: internal organ perforation (or other injury), bleeding in excess of 1000 mL.
From operation start to hospital discharge, assessed for an estimated total of days (1-7 days).
Rate of delayed complications
Adverse events during follow-up which requires re-hospitalisation or surgical re-intervention.
From hospital discharge and up to 2 years at single center and 1 year at multicenter
Secondary Outcomes (7)
Anatomical outcomes
2 years vs 1 year
Subjective outcomes and sexual function
2 years vs 1 year
Ultrasound mapping of mesh position in the pelvic floor and correlation to anatomical and subjective outcomes and sexual function
5, 7, 10 years
Measurement of Pain by patient self-reporting Visual analogue scale (VAS-scale)
Changes from baseline, 2, 5 and 10 years after surgery
Measurement of urinary incontinence by patient self-reporting Visual analogue scale (VAS-scale)
Changes from baseline, 2, 5 and 10 years after surgery
- +2 more secondary outcomes
Study Arms (1)
Single center vs. multicenter
Both Groups operated on by the same device (Transvaginal mesh Uphold TM Vaginal Support System) and in the same manner.
Interventions
Eligibility Criteria
112 patients from single center compared to 207 patients from 24 different centers
You may qualify if:
- Posthysterectomy prolapse of the vaginal apex, with or without cystocele, where the vaginal apex descends at least 50% of the total vaginal length
- Uterine prolapse, with or without cystocele, where the leading edge of the cervix descends at least 50% of the total vaginal length and TVL minus point C= ≤ 2 cm
- Prolapse specific pelvic symptom of pelvic heaviness and/or vaginal bulging
- Reproductive years in the past (biologically or reproductive decision)
- Being able to make an informed consent on participation
- Physically and cognitively capable of participating in the required follow-up
You may not qualify if:
- Posthysterectomy prolapse of the vaginal apex where the vaginal apex descends less than 50% of the total vaginal length regardless of whether a cystocele is present or not
- Uterine prolapse, with or without cystocele, where the leading edge of the cervix descends less than 50% of the total vaginal length
- If cervix elongation is present corresponding to: TVL minus point C= \>2 cm.
- If prolapse specific pelvic symptoms of pelvic heaviness and/or vaginal bulging are not present
- Previous or current pelvic organ cancer (regardless of treatment)
- Severe rheumatic disease
- Insulin treated diabetes mellitus
- Connective tissue disorders (SLE, Sjögrens syndrome, Marfans syndrome, Ehlers Dahnlos, collagenosis, polymyositis eller rheumatic myalgia)
- Current systemic steroid treatment
- Other clinically relevant pelvic disorders for which surgery is indicated including stress urinary incontinence, cervix elongation and posterior prolapse
- Decision to perform prolapse surgery using other medical devices/mesh
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior consultant, MD, PhD
Study Record Dates
First Submitted
February 1, 2017
First Posted
March 13, 2017
Study Start
March 4, 2015
Primary Completion
March 30, 2016
Study Completion
February 1, 2017
Last Updated
October 23, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share